Dana Harp

Dana Harp, PMP, is currently the Global Study Management Director at Pfizer, where they serve as the global protocol lead for a double-blinded phase III clinical trial across 16 countries. Prior to this role, Dana was a Senior Manager of Clinical Trial Operations at Seagen. They held various positions in clinical operations, including Senior Study Manager at Merck and Clinical Data Coordinator at PRA Health Sciences. Dana's educational background includes a Master of Science from Rochester Institute of Technology and a Bachelor's degree from Chestnut Hill College.